Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Tata India Pharma & Healthcare Fund-Regular Plan-Growth - Portfolio Analysis

Portfolio Overview

As of April 30, 2026

Icon Portfolio

Asset Allocation

Equity: 99.58%Others: 0.42%
Icon Portfolio

Market Cap

Large Cap: 26.27%Small Cap: 36.47%Mid Cap: 36.00%Others: 0.84%
Icon Portfolio

Number of stocks

38
Icon Portfolio

Top 10 Holdings

52.59% of portfolio

Market Cap of Equity

Large Cap
26.27%
Small Cap
36.47%
Mid Cap
36.00%
Others
0.84%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd9.87%
Divi's Laboratories Ltd5.92%
HealthCare Global Enterprises Ltd5.45%
Abbott India Ltd5.37%
Max Healthcare Institute Ltd Ordinary Shares5.17%
Cipla Ltd5.07%
Rainbow Childrens Medicare Ltd4.23%
Apollo Hospitals Enterprise Ltd4.06%
Mankind Pharma Ltd3.73%
Dr Reddy's Laboratories Ltd3.73%

Sector Allocation of Equity

Healthcare93.72%
Basic Materials5.19%
Financial Services0.67%

SIP Amount

Monthly SIP Date

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.